Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precancerous Conditions 1Melanoma 1Inflammatory Bowel Diseases 1Hepatitis C 1Hematologic Neoplasms 1Granulomatous Disease, Chronic 1Fatigue 1Crohn Disease 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Methylphenidate 6Modafinil 5Surveys and Questionnaires 3Acupuncture Therapy 3Yoga 2Therapeutics 2regorafenib 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1Water 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Sunitinib 1Standard of Care 1Sodium Chloride 1Radiotherapy 1Neurofeedback 1Midazolam 1Methods 1Mental Status and Dementia Tests 1Lactose 1Ketamine 1Infliximab 1Exercise Therapy 1Exercise 1Escitalopram 1Early Intervention, Educational 1Dextromethorphan 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Fatigue × Infliximab × Clear all
NCT00112749 2020-07-31

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Terminated
7 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡